Cargando…

Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales:	Minieri, Valentina, De Dominici, Marco, Nevalainen, Marja T., Calabretta, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298402/ https://www.ncbi.nlm.nih.gov/pubmed/30613358 http://dx.doi.org/10.18632/oncotarget.26412

Ejemplares similares

Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia
por: Porazzi, Patrizia, et al.
Publicado: (2021)

CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia
por: Mariani, Samanta Antonella, et al.
Publicado: (2016)

Targeting miR-126 in Ph+ acute lymphoblastic leukemia
por: Qiao, Junjing, et al.
Publicado: (2023)

Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2
por: Riva, Beatrice, et al.
Publicado: (2016)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
por: Bongiovanni, Deborah, et al.
Publicado: (2017)

Under the surface: scratching the acute lymphoblastic leukemia niche
por: Gower, Mark, et al.
Publicado: (2022)

Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia
por: Heltemes-Harris, Lynn M., et al.
Publicado: (2011)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
por: Kaczmarska, Agnieszka, et al.
Publicado: (2021)

Targeting the bone marrow microenvironment: a novel therapeutic strategy for pre-B acute lymphoblastic leukemia
por: Kotecha, Rishi S., et al.
Publicado: (2019)

Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia
por: Sharma, Nitesh D., et al.
Publicado: (2019)

Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
por: Saygin, Caner, et al.
Publicado: (2023)

Pediatric Acute Lymphoblastic Leukemia Emerging Therapies—From Pathway to Target
por: Ivanov, Anca Viorica, et al.
Publicado: (2023)

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
por: Conter, Valentino, et al.
Publicado: (2021)

INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapy
por: Herranz, Daniel
Publicado: (2022)

Central nervous system therapy in acute lymphoblastic leukemia: no more, no less
por: Rives, Susana
Publicado: (2023)

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia
por: Wang, Huafeng, et al.
Publicado: (2022)

STAT5 activation in B-cell acute lymphoblastic leukemia: damned if you do, damned if you don’t
por: Wang, Zhengqi, et al.
Publicado: (2016)

P403: HIGH EXPRESSION OF STAT5 INDICATES POOR PROGNOSIS IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Xu, Xiuli, et al.
Publicado: (2023)

miR-101 Represses T-Cell Acute Lymphoblastic Leukemia by Targeting CXCR7/STAT3 Axis
por: Yang, Xue-Yi, et al.
Publicado: (2019)

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells
por: Spagnuolo, Manuela, et al.
Publicado: (2019)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)

Targeting Telomere Biology in Acute Lymphoblastic Leukemia
por: Karow, Axel, et al.
Publicado: (2021)

Obesity and height in children and adolescents with acute lymphoblastic leukemia and its future management
por: Browne, Emily K., et al.
Publicado: (2019)

Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter
por: Ribera, Josep-Maria
Publicado: (2021)

Zebrafish MYC-induced leukemia models: unique in vivo systems to study B and T cell acute lymphoblastic leukemia
por: Borga, Chiara, et al.
Publicado: (2019)

Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway
por: Zhou, Yue, et al.
Publicado: (2021)

Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations
por: Ferrari, Anna, et al.
Publicado: (2023)

STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL and BCLXL following glucocorticoid treatment
por: van der Zwet, Jordy C.G., et al.
Publicado: (2022)

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph(+) acute lymphoblastic leukemia
por: Martinelli, Giovanni, et al.
Publicado: (2022)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
por: Dussiau, Charles, et al.
Publicado: (2015)

Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia
por: Dobrovinskaya, Oxana, et al.
Publicado: (2016)

New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update
por: Montaño, Adrián, et al.
Publicado: (2018)

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
por: Zheng, Ruyue, et al.
Publicado: (2020)

The clinical characteristics and prognosis in adult Ph negative acute lymphoblastic leukemia with TP53 aberrations
por: Fang, Qiuyun, et al.
Publicado: (2022)

Philadelphia-positive (PH+) acute lymphoblastic leukemia (ALL): developing strategies for curing this stubborn disease
por: Liam, Christopher Chin Keong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_99aut5ikp3tuol3nf0vsuuj567